Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era

The COVID-19 pandemic has resulted in a substantial increase in waiting times for cystoscopies, prompting concerns of delayed diagnoses and substandard surveillance of bladder cancer. Expanding the role of urinary biomarkers in diagnostic and surveillance pathways could be a strategy to address this...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Kenrick, Vinnakota, Krishna, Sharma, Anand, Kelly, John, Dasgupta, Prokar, Vasdev, Nikhil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745709/
https://www.ncbi.nlm.nih.gov/pubmed/33335321
http://dx.doi.org/10.1038/s41585-020-00419-z
_version_ 1783624659378372608
author Ng, Kenrick
Vinnakota, Krishna
Sharma, Anand
Kelly, John
Dasgupta, Prokar
Vasdev, Nikhil
author_facet Ng, Kenrick
Vinnakota, Krishna
Sharma, Anand
Kelly, John
Dasgupta, Prokar
Vasdev, Nikhil
author_sort Ng, Kenrick
collection PubMed
description The COVID-19 pandemic has resulted in a substantial increase in waiting times for cystoscopies, prompting concerns of delayed diagnoses and substandard surveillance of bladder cancer. Expanding the role of urinary biomarkers in diagnostic and surveillance pathways could be a strategy to address this problem, and several novel biomarkers have shown promise for this purpose.
format Online
Article
Text
id pubmed-7745709
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-77457092020-12-18 Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era Ng, Kenrick Vinnakota, Krishna Sharma, Anand Kelly, John Dasgupta, Prokar Vasdev, Nikhil Nat Rev Urol Comment The COVID-19 pandemic has resulted in a substantial increase in waiting times for cystoscopies, prompting concerns of delayed diagnoses and substandard surveillance of bladder cancer. Expanding the role of urinary biomarkers in diagnostic and surveillance pathways could be a strategy to address this problem, and several novel biomarkers have shown promise for this purpose. Nature Publishing Group UK 2020-12-17 2021 /pmc/articles/PMC7745709/ /pubmed/33335321 http://dx.doi.org/10.1038/s41585-020-00419-z Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Ng, Kenrick
Vinnakota, Krishna
Sharma, Anand
Kelly, John
Dasgupta, Prokar
Vasdev, Nikhil
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
title Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
title_full Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
title_fullStr Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
title_full_unstemmed Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
title_short Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
title_sort urinary biomarkers to mitigate diagnostic delay in bladder cancer during the covid-19 era
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745709/
https://www.ncbi.nlm.nih.gov/pubmed/33335321
http://dx.doi.org/10.1038/s41585-020-00419-z
work_keys_str_mv AT ngkenrick urinarybiomarkerstomitigatediagnosticdelayinbladdercancerduringthecovid19era
AT vinnakotakrishna urinarybiomarkerstomitigatediagnosticdelayinbladdercancerduringthecovid19era
AT sharmaanand urinarybiomarkerstomitigatediagnosticdelayinbladdercancerduringthecovid19era
AT kellyjohn urinarybiomarkerstomitigatediagnosticdelayinbladdercancerduringthecovid19era
AT dasguptaprokar urinarybiomarkerstomitigatediagnosticdelayinbladdercancerduringthecovid19era
AT vasdevnikhil urinarybiomarkerstomitigatediagnosticdelayinbladdercancerduringthecovid19era

Ejemplares similares